PATENT CLAIM ANALYSIS

Application Number: 16167746
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "575000"]

Abstract:
This pharmaceutical composition contains a hvdroxamic acid derivative, or a salt thereof, and a solubilizer, said hydroxamic acid derivative being selected from among (2S)-2-((4-((4-((1S)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N′,2- dimethylmalonamide, (2S)-2-((4((4-((1R)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N-hydroxy-N′,2-dimethylmalonamide, and (2S)-N-hydroxy-2-((4-((4-((1S)-1-hydroxy-2-methoxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-N′,2-dimethylmalonamide. The pharmaceutical composition demonstrates strong antibacterial activity, has excellent solubility in water, and is useful as a drug.

Claim (Index 17):
A method of inhibiting LpxC, comprising administering the pharmaceutical composition according to  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 2.47273
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15510487', '14777156', '15510524', '15179751', '14969930']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7159681558096882
- 35 USC 102 Novelty (BERT): 0.6262525564250441
- Combined Prediction Score: 0.7069965958712239
- Mean Citation Score: 344.237766
- Max Citation Score: 573.14264
- Similarity Product: 521.6022465898849

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test